Related Experiment Video
Updated: Jan 29, 2026

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Identifying and Treating Nonalcoholic Fatty Liver Disease
Christine M Hunt1, Marsha J Turner1, Elizabeth J Gifford1
1is a Physician Affiliate, is a Research Health Science Specialist at the Cooperative Studies Program Epidemiology Center, and is a Hepatology Clinical Pharmacy Specialist, all at Durham Veterans Affairs Health Care System in North Carolina. is an Assistant Research Professor at the Sanford School of Public Policy at Duke University in Durham. is a Professor of Medicine at the VA Ann Arbor Healthcare Systems in Michigan and at the University of Michigan in Ann Arbor. Christine Hunt also is an Adjunct Associate Professor of Medicine at Duke University Medical Center in Durham, North Carolina.
Achieving a 7% or greater weight loss can significantly improve non-alcoholic fatty liver disease (NAFLD). This finding highlights the crucial role of weight management in mitigating liver disease progression.
Area of Science:
- Hepatology
- Metabolic Disorders
- Gastroenterology
Background:
- Non-alcoholic fatty liver disease (NAFLD) is a growing global health concern.
- NAFLD is characterized by excessive fat accumulation in the liver, unrelated to alcohol consumption.
- Progression of NAFLD can lead to serious liver complications, including cirrhosis and hepatocellular carcinoma.
Purpose of the Study:
- To determine the efficacy of weight loss as an intervention for NAFLD.
- To establish a target weight loss percentage for significant improvement in NAFLD.
Main Methods:
- Systematic review and meta-analysis of existing clinical trials.
- Inclusion of studies focusing on lifestyle interventions and their impact on liver fat content.
- Quantitative assessment of the correlation between percentage of weight loss and NAFLD severity.
Main Results:
- A statistically significant improvement in NAFLD was observed with a weight loss of 7% or greater.
- Lower percentages of weight loss showed a less pronounced, though still potentially beneficial, effect.
- The degree of NAFLD improvement correlated positively with the amount of weight lost.
Conclusions:
- A minimum of 7% weight loss is recommended for patients with NAFLD to achieve meaningful clinical improvement.
- Weight management is a cornerstone therapy for non-alcoholic fatty liver disease.
- Further research should explore optimal strategies for sustained weight loss in NAFLD management.
More Related Videos
09:27Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish
Published on: April 1, 2021
11:08The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy
Published on: March 13, 2014
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Liver Histology
Hepatocytes perform a variety of essential functions. They secrete...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...